π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Study to determine the best dose of stereotactic body radiation therapy (SB...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2018-03-15
Trial ID
NCT03431948
Treatments Being Tested
The purpose of this Pilot Study is to investigate the safety, side effects,...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2016-03-08
Trial ID
NCT02652455
This platform trial will evaluate various immunotherapy combinations given ...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2016-03-28
Trial ID
NCT02451982
Treatments Being Tested
The purpose of this study is to determine which doses of Urelumab and Nivol...
Status
Terminated
Location
Stanford University School Of Medicine
Start Date
2014-09-29
Trial ID
NCT02253992
The purpose of this study is to assess the safety and tolerability of BMS-6...
Status
Completed
Location
Local Institution
Start Date
2015-11-06
Trial ID
NCT02534506
This study evaluates the post cystectomy CD8+ tumor response of patients re...
Status
Active Not Recruiting
Location
UCLA Institute of Urologic Oncology
Start Date
2017-05-16
Trial ID
NCT02845323
Treatments Being Tested
Open label, phase I-II study to evaluate the safety and activity of intratu...
Status
Unknown
Location
Clinica Universidad de Navarra
Start Date
2019-01-30
Trial ID
NCT03792724
Treatments Being Tested
This phase I trial studies the safety and best dose of anti-LAG-3 (anti-LAG...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2016-08-24
Trial ID
NCT02658981